Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Randomized, double-blind, vehicle-controlled, parallel group, multi-dose study of TDM-105795 in male subjects with androgenetic alopecia
Epistemonikos ID: 47d00ea2bf9bfc9d470ad226e0b4b89d668b7a7b
First added on: Feb 19, 2024